RECIST, which stands for Response Evaluation Criteria in Solid Tumors, is a set of standardized guidelines used to assess how well a tumor is responding to treatment. These criteria are pivotal for determining the efficacy of anticancer therapies in clinical trials. The guidelines primarily focus on measuring changes in tumor size as seen through imaging techniques such as CT or MRI scans.
